Beta-agonists alter metabolism of several important pathways. They possess lipolytic and antilipogenic properties and improve nitrogen retention. Glycolysis, lactate production and oxygen consumption are increased, while plasma insulin levels are decreased and adipocytes become less sensitive to insulin. Energy expenditure is increased by beta-agonists, partly due to an extra heat production.
I. Introduction
A major goal of animal husbandry has been the improvement in growth of meat producing animals. This goal can be achieved by different means. Breeds are characterized by different growth capacities. Hence, crossbreeding offers an opportunity to increase daily gain. Even in fast growing animals liveweight gain can be enhanced by feeding an appropriate diet. Besides selection and nutrition it is possible to modify the growth process with anabolic agents (G ALBRAITH & To pp s, 1981) . Furthermore, in nonruminant as in ruminant livestock production, antibiotics are largely used as feed additives for their growth promoting effect (V ISEK , 1978 ; M AC G REGOR , 1983) . Another approach to improve growth rate would be the auto-immunization against somatostatin (S PENCE x et al., 1983) , although the positive effect has not been confirmed (Gn LS R A tTtt et al. , 1985) . Different BAA, such as cimaterol, clenbuterol (D ALRYMPLE et al., 1984a and b) or L-640,033 (M UIR et al. , 1985) increased liveweight gain in broilers. They are incorporated in the diet at levels ranging from 0.125 to 2 ppm for cimaterol (D ALRYMPLE et al., 1984a) , 0.25 to 4 ppm for clenbuterol (D ALRYMPLE et al. , 1984b) and 0.25 to 2 ppm for L-640,033 (M UIR et al., 1985) .
Maximum growth rate improvement is observed with cimaterol at 0.25 ppm (D AL -RYMPLE et al., 1984a) and 0.5 to 1 ppm clenbuterol and L-640,033 (D A r.xYMrr.E et al., 1984b ; MurR et al., 1985) . Besides gain, feed efficiency is also improved. Feed : gain ratio was 4 and 5 % lower for 1 ppm clenbuterol (Dnr.xYMrr.E et al. , 1984b) and 10 % lower for 1 ppm L-640,033 (MurR et al., 1985) . The general effects of BAA were confirmed for different breeds : Hubbard chickens (D ALRYMPLE et al. , 1984b) and Arbor Acre x White Mountain (MmR et al., 1985) .
Another effect of BAA is the enhanced dressing percentage, which was significantly higher than in control chickens (D ALRYMPLE et al., 1984a and b) . BAA reduce carcass fat content, as observed with cimaterol (D ALRYMPLE et al. , 1984a) as well as for clenbuterol (Da.r.xYmtrr.E et al. , 1984b) . However, when the abdominal fat content was investigated, the amount was significantly reduced in female broilers but was not lowered in males (D ALRYMPLE et al., 1984b) . It is not clear why abdominal fat is unresponsive to BAA in males. The reduction in carcass fat is similar to the one observed in chickens after adrenalin infusion (C UNNINGHAM , 1963) . Positive effects of clenbuterol are not nullified by the inclusion of a 3-day withdrawal period (D ALRYMPLE et al., 1984b) . Moisture content in meat is increased by the drug treatment (D ALRYMPLE et al. , 1984b (D ALRYMPLE et al. , 1984c ; JorrES et al. , 1985 ; PRINCE et al. , 1985 ; M OSER et al. , 1986) , with levels of 0.05, 0.2, 0.25, 0.5 and 1 ppm. Gain is not affected by cimaterol, except in a trial of D ALRYMPLE et al. (1984c) where pigs fed 1 ppm grew significantly slower (P < 0.05) than other animals. When clenbuterol was fed at 1 ppm (RiCKs et al. , 1984a ) daily gain of barrows was also reduced (P < 0.05), but not for gilts. Rate gain was unaffected at lower levels. These findings are not in agreement with those observed with broilers, where gain was significantly increased by BAA.
Feed intake is reduced linearly (P < 0.05) with increasing cimaterol levels (J ONES et al. , 1985 ; PRINCE et al. , 1985 and MosEx et al. , 1986) . Effects on feed efficiency were not always the same. D ALRYMPLE et al. (1984c) and M OSER et al. (1986) found no significant effect, while J ONES et al. (1985) found a positive effect, but there was no apparent correlation of level of cimaterol to feed efficiency. P RINCE et al. (1985) found a slightly improved feed conversion, but the effect was not significant.
Dressing percent was not affected in experiments of MosEx et al. (1986) and B EKAERT et al. (1987) , while it was increased with 1 ppm cimaterol (J ONES et al., 1985) . BAA always reduced backfat thickness (D ALRYMPLE et aI. , 1984c ; J ONES et al. , 1985 ; M OSER et al., 1986 (J ONES et al., 1985) . Colour of the longissimus muscle was not or hardly affected by cimaterol (J ONES et al. , 1985 ; M OSER et al. , 1986 ; B EKAERT et al. , 1987) .
The withdrawal of cimaterol for 7 days resulted in a compensatory fat deposition (J ONES et al. , 1985) . During the withdrawal period, pigs consumed 0.31 kg more feed per day than control animals, which helps to provoke the increased fat accretion.
The result obtained by PRINCE et al. (1985) , with pigs fed 1 ppm cimaterol with 7-day withdrawal did not reveal a complete compensatory effect on feed intake or backfat thickness, although both were increased, compared with 1 ppm and no withdrawal period.
C. Effects in cattle and sheep
The administration of 0.1 or 1 ppm elenbuterol to veal calves did not affect liveweight gain, feed consumption and conversion of feed to gain (W ILLIAMS et al., 1986) . However, dressing percentage was significantly increased and fat deposition was reduced.
Feeding 10 mg clenbuterol per head per day to steers did not alter growth rate (RICKS et al. , 1984b (BAKER et al., 1984 ; BeExMntvrr et al., 1986a) . In other experiments B EE xMnNN et al. , 1986a ; K IM et al. , 1986) (H ANRAHAN et al., 1986 ; Bouc Q u E et al., 1987) . Experiments of BAKER et al. (1984) and B EERMANN et al. (1986a) with lambs, fed clenbuterol and cimaterol respectively, revealed a significantly higher dressing percent for both drugs. These authors also reported muscle hypertrophy. These observations are in accordance with those obtained in pigs by J ONES et al. (1985) . H AMBY et al. (1985) also found muscle hypertrophy in sheep caused by treatment with clenbuterol. In steers (RiCKs et al. , 1984b) and in lambs (BAKER et a1. , 1984 ; D ALRYMPLE et al. , 1985 ; B EERMANN et al., 1986a) (M ICHAUX et al., 1982) . Insulin and cAMP are involved in the activity of BAA. The mode of action is dealt with in the following section.
E. Effect of age on efficacy of BAA The results presented in tables 1, 2 and 3 must be interpreted with care, because a lot of experimental circumstances differ. In several species the performance response to BAA treatment is enhanced with animal maturity. Lambs with an initial weight of about 40 kg gained faster than controls when fed 2 ppm clenbuterol, but the same dose had no effect on gain in lambs weighing initially 37.5 kg (BAKER et al., 1984) . Also B EERMANN et al. (1986a) (J OHNSSON et al., 1985) and pigs (M ACHLIN , 1972) . If sex hormones are involved in the regulation of (3-adrenergic receptors (STILES et al. , 1984) , than the effect of BAA may be different before and after the onset of the puberty, and between males and females. Based on investigations with cimaterol Wt L SOrr et al. (1987) (R ICKES et al., 1985) . This across species similarity indicates that the action of BAA occurs close to the basic control of lipid and protein metabolism. The effect is similar for oral and parenteral administration (D ALRYMPLE et (11. , 1985 ; H ANRAHAN et al. , 1986 (V ERNON , 1981 ; D UQUETTE et al., 1984) . In birds glucagon rather than catecholamines appears to be the dominant lipolytic hormone (BuTLER, 1975) . The mechanism of lipolysis in adipose tissue through adrenalin or other adrenergic agents is shown in figure 2.
Via 13 1-and (3 2 receptors adrenalin elevates cyclic adenosine 3', 5' monophosphate (cAMP) through the stimulation of adenyl cyclase. cAMP is hydrolyzed by a phosphodiesterase to yield ordinary 5'-AMP. GTP plays a keyrole in the regulation of adenyl cyclase. It exerts a biphasic effect, i.e., activation is observed at low concentration whereas inhibition is produced at high concentration (FAIN & G ARCIA -S AINZ , 1983). A working model for the regulation on the adenyl cyclase by BAA is described by STILES et al. (1984) . The intra-cellular effect of cAMP is the activation of a protein kinase, which in turn activates triglyceride lipase. Finally free fatty acids are released (B LUM et al., 1982) . This mechanism is inhibited by insulin, but it is not clear whether insulin stimulates the phosphodiesterase activity, or depresses the adenyl cyclase activity, or affects both processes (S IDDLE & H ALES , 1975 ; V ERNON , 1981 MILLER et al., 1986 ). An inhibition of the uptake and esterification of fatty acids by clenbuterol in ovine adipose tissue was previously reported by T HO xNTON et al. (1985) , together with an increased lipolysis. (1972) demonstrated that cerebroventricular injections of dl-isoproterenol-HCI in satiated sheep and steers resulted in an increased feed intake. However higher doses provoked anorexia in sheep, but not in steers. A high dosage level of 500 mg per day, administrated as a top-dressing to the diet, reduced feed intake in steers, but only during the first 56 days of the treatment (R l cxs et al., 1984b) . G RAHAM et al. (1982) found a decreased rumen motility in sheep infused with adrenalin. If rumen motility is decreased, a lower rate of passage could be expected, resulting in an improved digestibility. However, no effect on digestibility in sheep was observed when cimaterol was incorporated in the diet (B OUCQUE et al. , 1987 ; K IM et al. , 1987c) . Rtcxs et al. (1984b) observed a significant reduction in total rumen volatile fatty acid concentration in steers fed 500 mg clenbuterol per day, a dosage of fifty times the use level. It was not determined whether the lower volatile fatty acid concentration was the result of a reduced rumen fermentation or a faster uptake of the fatty acids. This negative effect was not reported for 100 mg clenbuterol per head per day (Rrcxs et al. , 1984b) or 4 ppm cimaterol (B OUCQUE et al. , 1987) . Experiments with pigs (CurrrnrroawM et al. , 1963) did not reveal an altered digestibility due to adrenalin infusions.
The increased metabolism and the hypertrophy of type II muscle fibres may affect meat quality. Hypertrophy of white fibres, provoked by clenbuterol in heifers (COLE-MAN et al., 1986) , could result in a paler meat. The darkness value for the longissimus muscle in lambs fed cimaterol was lower (B EERMANN et al. , 1985a (B EERMANN et al., 1985a) , probably due to lower glycogen levels (see above).
As carcasses contain less subcutaneous fat when treated with BAA, they may be more susceptible to cold shortening (MARSH, 1975) , which decreases meat tenderness. Tenderness was unaltered in lambs when they received cimaterol (B EERMANN et al. , 1985a) . In pigs Warner-Bratzler shear force values were slightly higher for cimaterol treated animals (J ONES et al. , 1985) . The higher shear force values obtained in lambs with the clenbuterol treatment (H AMBY et al. , 1985) were attributed to cold shortening, but other factors could also be involved. On the other hand, BAA may also improve meat tenderness. BAA increase muscle thickness, and as a result the connective tissue component of muscle structure could be decreased (DuntorrT, 1978) .
Moisture content was mostly increased by BAA, in the hindquarters of sheep (B AKER et al., 1984) , in the carcass of steers (RicKs et al., 1984b) , in the meat of pigs (J ONES et al., 1985) and in the carcass of poultry (D ALRYMPLE et al., 1984b 
